Alpheus Bingham, PhD, is a pioneer in the field of open innovation and an advocate of collaborative approaches to research and development. He is a cofounder and director of InnoCentive, Inc., a web-based community that matches companies facing R&D challenges with scientists who propose solutions. His book, The Open Innovation Marketplace, introduces groundbreaking strategies for leveraging the world's best innovation sources to derive more value from new products, services, and business models with less risk.
Mr. Bingham spent more than 25 years with Eli Lilly and Company, where he was instrumental in creating and developing Eli Lilly's portfolio management process as well as establishing the divisions of Re-search Acquisitions; the Office of Alliance Management; and e.Lilly, a business innovation unit.
He currently serves on the boards of directors of InnoCentive, Inc., and Collaborative Drug Discovery, Inc., as well as the advisory boards of Elanco Animal Health; the Center for Collective Intelligence at MIT; the Business Innovation Factory; Coalesix; and YourEncore, where he is helping launch a business intelligence platform centered on prediction markets.
He has lectured extensively and serves as a visiting scholar at the National Center for Supercomputing Applications at the University of Illinois at Urbana-Champaign. Mr. Bingham was the recipient of the Economist's Fourth Annual Innovation Summit "Business Process Award" for InnoCentive. He was also named as one of Project Management Institute's "Power 50" leaders in 2005.
Mr. Bingham received a BS in chemistry from Brigham Young University and a PhD in organic chemistry from Stanford University.